Systematic review of long-term Xingnao Kaiqiao needling effcacy in ischemic stroke treatment

OBJECTIVE: To systematically evaluate the long-term effect and safety of Xingnao Kaiqiao needling method in ischemic stroke treatment. DATA RETRIEVAL: We retrieved relevant random and semi-random controlled trials that used the Xingnao Kaiqiao needling method to treat ischemic stroke compared with v...

Full description

Bibliographic Details
Main Authors: Zhi-xin Yang, Jia-hong Xie, Yong-ping Liu, Guang-xin Miao, Ying-han Wang, Sheng-mei Wu, Yuan Li
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Neural Regeneration Research
Subjects:
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2015;volume=10;issue=4;spage=583;epage=588;aulast=Yang
_version_ 1818529687164420096
author Zhi-xin Yang
Jia-hong Xie
Yong-ping Liu
Guang-xin Miao
Ying-han Wang
Sheng-mei Wu
Yuan Li
author_facet Zhi-xin Yang
Jia-hong Xie
Yong-ping Liu
Guang-xin Miao
Ying-han Wang
Sheng-mei Wu
Yuan Li
author_sort Zhi-xin Yang
collection DOAJ
description OBJECTIVE: To systematically evaluate the long-term effect and safety of Xingnao Kaiqiao needling method in ischemic stroke treatment. DATA RETRIEVAL: We retrieved relevant random and semi-random controlled trials that used the Xingnao Kaiqiao needling method to treat ischemic stroke compared with various control treatments such as conventional drugs or other acupuncture therapies. Searched databases included China National Knowledge Infrastructure, Weipu Information Resources System, Wanfang Medical Data System, Chinese Biomedical Literature Database, Cochrane Library, and PubMed, from May 2006 to July 2014. SELECTION CRITERIA: Two authors independently conducted literature screening, quality evaluation, and data extraction. The quality of articles was evaluated according to the Cochrane Reviewers′Handbook 5.1, and the study was carried out using Cochrane system assessment methods. RevMan 5.2 was used for meta-analysis of the included studies. MAIN OUTCOME MEASURES: Mortality rate, recurrence rate, and disability rate were observed. RESULTS: Nine randomized and semi-randomized controlled trials treating 931 cases of ischemic stroke were included in this review. Meta-analysis results showed that there were no significant differences in mortality reduction (risk ratio (RR) = 0.58, 95% confidence interval (CI): 0.17-1.93, Z = 0.89, P = 0.37) or recurrence rate (RR = 0.55, 95%CI: 0.18-1.70, Z = 1.04, P = 0.30) of ischemic stroke patients between the Xingnao Kaiqiao needling and control treatment groups. However, the Xingnao Kaiqiao needling method had a tendency towards higher efficacy in mortality reduction and recurrence rates. The Xingnao Kaiqiao needling method was significantly better than that of the control treatment in reducing disability rate (RR = 0.51, 95%CI: 0.27-0.98, Z = 2.03, P < 0.05). CONCLUSION: The Xingnao Kaiqiao needling method has a better effect than control treatment in reducing disability rate. The long-term effect of Xingnao Kaiqiao needling against ischemic stroke is better than that of control treatment. However, the limitations of this study limit the strength of the conclusions. Randomized controlled trials with a strict, reasonable design, and multi-center, large-scale samples and follow-up are necessary to draw conclusions about Xingnao Kaiqiao needling.
first_indexed 2024-12-11T17:10:03Z
format Article
id doaj.art-6483f18487d5481c95bbd574d6cd0c36
institution Directory Open Access Journal
issn 1673-5374
language English
last_indexed 2024-12-11T17:10:03Z
publishDate 2015-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Neural Regeneration Research
spelling doaj.art-6483f18487d5481c95bbd574d6cd0c362022-12-22T00:57:34ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742015-01-0110458358810.4103/1673-5374.155431Systematic review of long-term Xingnao Kaiqiao needling effcacy in ischemic stroke treatmentZhi-xin YangJia-hong XieYong-ping LiuGuang-xin MiaoYing-han WangSheng-mei WuYuan LiOBJECTIVE: To systematically evaluate the long-term effect and safety of Xingnao Kaiqiao needling method in ischemic stroke treatment. DATA RETRIEVAL: We retrieved relevant random and semi-random controlled trials that used the Xingnao Kaiqiao needling method to treat ischemic stroke compared with various control treatments such as conventional drugs or other acupuncture therapies. Searched databases included China National Knowledge Infrastructure, Weipu Information Resources System, Wanfang Medical Data System, Chinese Biomedical Literature Database, Cochrane Library, and PubMed, from May 2006 to July 2014. SELECTION CRITERIA: Two authors independently conducted literature screening, quality evaluation, and data extraction. The quality of articles was evaluated according to the Cochrane Reviewers′Handbook 5.1, and the study was carried out using Cochrane system assessment methods. RevMan 5.2 was used for meta-analysis of the included studies. MAIN OUTCOME MEASURES: Mortality rate, recurrence rate, and disability rate were observed. RESULTS: Nine randomized and semi-randomized controlled trials treating 931 cases of ischemic stroke were included in this review. Meta-analysis results showed that there were no significant differences in mortality reduction (risk ratio (RR) = 0.58, 95% confidence interval (CI): 0.17-1.93, Z = 0.89, P = 0.37) or recurrence rate (RR = 0.55, 95%CI: 0.18-1.70, Z = 1.04, P = 0.30) of ischemic stroke patients between the Xingnao Kaiqiao needling and control treatment groups. However, the Xingnao Kaiqiao needling method had a tendency towards higher efficacy in mortality reduction and recurrence rates. The Xingnao Kaiqiao needling method was significantly better than that of the control treatment in reducing disability rate (RR = 0.51, 95%CI: 0.27-0.98, Z = 2.03, P < 0.05). CONCLUSION: The Xingnao Kaiqiao needling method has a better effect than control treatment in reducing disability rate. The long-term effect of Xingnao Kaiqiao needling against ischemic stroke is better than that of control treatment. However, the limitations of this study limit the strength of the conclusions. Randomized controlled trials with a strict, reasonable design, and multi-center, large-scale samples and follow-up are necessary to draw conclusions about Xingnao Kaiqiao needling.http://www.nrronline.org/article.asp?issn=1673-5374;year=2015;volume=10;issue=4;spage=583;epage=588;aulast=Yangspinal cord injurypropriospinal systemneural plasticityfiber sproutingneural repaircompensationregenerationpropriospinal detoursneurotrophic factorscell-adhesive ligandsdorsal root gangliaL1CAMnerve growth factorbiomaterialselastin-like proteinsAlzheimer′s diseaseAMPKapoptosisautophagycentral nervous systemCCN4EGFdiabetes mellituserythropoietinEPOFGFIGF-1mTORneuronneuropathyoxidative stresspsychiatricstem cellsWISP1Wntperipheral nerve injurynerve graftnerve conduitWallerian degenerationneurotrophic factorsveinsautograftsnerve regenerationnerve regenerationneuroprotectionresveratrolcerebral ischemiacerebral infarctionmatrix metalloproteinasemolecular dockingextracellular matrixneural regenerationnerve regenerationvagus nerve stimulationcerebral ischemiainflammatory cytokinesinfarct volumeneurological functionNSFC grantsneural regenerationnerve regenerationXingnao Kaiqiao needling methodischemic strokerandomized controlled trialsystemic reviewsmeta-analysislong-term efficacymortalityrecurrencedisabilityadverse reactionshealth economics indicatorsneural regeneration
spellingShingle Zhi-xin Yang
Jia-hong Xie
Yong-ping Liu
Guang-xin Miao
Ying-han Wang
Sheng-mei Wu
Yuan Li
Systematic review of long-term Xingnao Kaiqiao needling effcacy in ischemic stroke treatment
Neural Regeneration Research
spinal cord injury
propriospinal system
neural plasticity
fiber sprouting
neural repair
compensation
regeneration
propriospinal detours
neurotrophic factors
cell-adhesive ligands
dorsal root ganglia
L1CAM
nerve growth factor
biomaterials
elastin-like proteins
Alzheimer′s disease
AMPK
apoptosis
autophagy
central nervous system
CCN4
EGF
diabetes mellitus
erythropoietin
EPO
FGF
IGF-1
mTOR
neuron
neuropathy
oxidative stress
psychiatric
stem cells
WISP1
Wnt
peripheral nerve injury
nerve graft
nerve conduit
Wallerian degeneration
neurotrophic factors
veins
autografts
nerve regeneration
nerve regeneration
neuroprotection
resveratrol
cerebral ischemia
cerebral infarction
matrix metalloproteinase
molecular docking
extracellular matrix
neural regeneration
nerve regeneration
vagus nerve stimulation
cerebral ischemia
inflammatory cytokines
infarct volume
neurological function
NSFC grants
neural regeneration
nerve regeneration
Xingnao Kaiqiao needling method
ischemic stroke
randomized controlled trial
systemic reviews
meta-analysis
long-term efficacy
mortality
recurrence
disability
adverse reactions
health economics indicators
neural regeneration
title Systematic review of long-term Xingnao Kaiqiao needling effcacy in ischemic stroke treatment
title_full Systematic review of long-term Xingnao Kaiqiao needling effcacy in ischemic stroke treatment
title_fullStr Systematic review of long-term Xingnao Kaiqiao needling effcacy in ischemic stroke treatment
title_full_unstemmed Systematic review of long-term Xingnao Kaiqiao needling effcacy in ischemic stroke treatment
title_short Systematic review of long-term Xingnao Kaiqiao needling effcacy in ischemic stroke treatment
title_sort systematic review of long term xingnao kaiqiao needling effcacy in ischemic stroke treatment
topic spinal cord injury
propriospinal system
neural plasticity
fiber sprouting
neural repair
compensation
regeneration
propriospinal detours
neurotrophic factors
cell-adhesive ligands
dorsal root ganglia
L1CAM
nerve growth factor
biomaterials
elastin-like proteins
Alzheimer′s disease
AMPK
apoptosis
autophagy
central nervous system
CCN4
EGF
diabetes mellitus
erythropoietin
EPO
FGF
IGF-1
mTOR
neuron
neuropathy
oxidative stress
psychiatric
stem cells
WISP1
Wnt
peripheral nerve injury
nerve graft
nerve conduit
Wallerian degeneration
neurotrophic factors
veins
autografts
nerve regeneration
nerve regeneration
neuroprotection
resveratrol
cerebral ischemia
cerebral infarction
matrix metalloproteinase
molecular docking
extracellular matrix
neural regeneration
nerve regeneration
vagus nerve stimulation
cerebral ischemia
inflammatory cytokines
infarct volume
neurological function
NSFC grants
neural regeneration
nerve regeneration
Xingnao Kaiqiao needling method
ischemic stroke
randomized controlled trial
systemic reviews
meta-analysis
long-term efficacy
mortality
recurrence
disability
adverse reactions
health economics indicators
neural regeneration
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2015;volume=10;issue=4;spage=583;epage=588;aulast=Yang
work_keys_str_mv AT zhixinyang systematicreviewoflongtermxingnaokaiqiaoneedlingeffcacyinischemicstroketreatment
AT jiahongxie systematicreviewoflongtermxingnaokaiqiaoneedlingeffcacyinischemicstroketreatment
AT yongpingliu systematicreviewoflongtermxingnaokaiqiaoneedlingeffcacyinischemicstroketreatment
AT guangxinmiao systematicreviewoflongtermxingnaokaiqiaoneedlingeffcacyinischemicstroketreatment
AT yinghanwang systematicreviewoflongtermxingnaokaiqiaoneedlingeffcacyinischemicstroketreatment
AT shengmeiwu systematicreviewoflongtermxingnaokaiqiaoneedlingeffcacyinischemicstroketreatment
AT yuanli systematicreviewoflongtermxingnaokaiqiaoneedlingeffcacyinischemicstroketreatment